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ABSTRACT: First medical contact for couples trying for a child will usually emphasise the array of assistance available to ‘help them have their
own child’, usually with options involving ART, after diagnosis. For many poorer prognosis couples, this means repetitive unsuccessful cycles
of invasive and stressful treatment. What is sometimes lost at this stage is a reﬂection on the likelihood of success of different options, which
may lead patients to focus on hoping for their own ‘genetic’ progeny, but failing to consider the alternative and potentially more successful
other options, including donation and adoption, for achieving parenthood of a child. Factors not only such as female age but also advanced
requirements such as preimplantation genetic testing or even mitochondrial replacement therapies all have reduced chances of success but
further tend to reinforce the importance of a genetic link. The ﬁnancial, physical and psychosocial burden associated with cumulative failure
also lead to a higher probability of dropout and consequently an even higher probability of remaining in involuntary childlessness. We advocate
formulation of a detailed roadmap for discussion of parenthood, with reference explanation to genetics and epigenetics, which gives due
consideration to the psychological effects from the beginning to end of the treatment process, alongside a balanced consideration of the
likelihood of treatment success and discussion of other options. Only when we provide patients with the service of a clear and transparent
discussion of these matters, we will really realise the true potential of our ﬁeld, which may then be better considered as assisted families.
Key words: ART / donation / age-related fertility / fertility counselling / genetics
Introduction
A conception on 10 November 1977, followed by the healthy birth
of Louise Brown on 25 July 1978, marked the start of an explosion in
assisted conception provision and a generation of hope for subfertile
couples. Before IVF, there were three main simple choices: acceptance
of childlessness; adoption; or when the problemwas male, using donor
sperm. IVF changed this paradigm, not only by adding a new option but
also by providing a new hope. Since 1978, these options have prolifer-
ated. Notable developments that have increased the chance of having
their own genetic children include ICSI, reducing the need for sperm
donation (Palermo et al., 1992); pre-implantation diagnostic testing
(Handyside et al., 1992) and most recently mitochondrial replacement
techniques (MRTs; Zhang et al., 2017). The potential importance of
a child being parents’ ‘genetically own’ is also further emphasised by
developments in sperm and egg freezing, including social egg freezing,
gonadal tissue preservation and stem cell-generated gametes, the latter
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being touted as just over the horizon. With such a wide range of
techniques and science being discussed and portrayed in the media, the
non-specialist could be forgiven for thinking the age where everyone
can have their own genetic progeny is upon us. In fact, the reality is
that for many couples, assisted conception techniques are often not
particularly successful, and the chance of ‘own genes’ success may be
rather low or zero. Equally, some of the more complex techniques
(e.g. MRT, oocyte activation or stem cells) bear an unknown and
unquantiﬁable risk to the potential child and future generations.
Concurrently, we have been reminded that the diagnosis of infertility
is somewhat arbitrary, and both clinicians and patients like to go on
with treatment even in the case of unproven therapies (Evers, 2016).
For example, despite the fact that expectant management should
be prescribed to younger couples with good prognosis (Donckers
et al., 2011), one-third is overtreated (Kersten et al., 2014). There
are, however, no studies on overtreatment of couples with poor
prognosis. This seems of particular importance considering, ﬁrst, the
D
ow
nloaded from
 https://academ
ic.oup.com
/hum
rep/advance-article-abstract/doi/10.1093/hum
rep/dez256/5698586 by U
niversidade do Porto user on 13 January 2020
2 Kirkman-Brown and Martins
success rates of using donation and, second, the role of age-related
fertility and the fact that older couples (female age≥ 40 years) seek
fertility treatment over six times more frequently than younger ones
(de Graaff et al., 2011).
In a situation where ﬁnances and emotions are usually both limit-
ing, it may be time to re-examine our eagerness to reproduce our
personal genes. Our coding genes may be sufficiently indistinct from
another potential gamete donor that considering them so selﬁsh (in the
Richard Dawkins’ sense) that they are all that matters in parenthood
is misguided. It is also of note that in 21st century life, ‘families’ and
morality around progeny have changed beyond recognition, so this
concept of needing to pass on our own genes (for inheritance or future
security) is perhaps outdated in the developed world; equally in African
cultures, many women (unlike their partners) may have a strong need
for a child even though it need not necessarily be their own offspring
(Gerrits and Shaw, 2010). Still, there is a societal signiﬁcance tied to
the idea of having a genetically related child (Segers et al., 2019). The
present article advocates addressing possible concerns about donor
conception for poorer prognosis patients from the time of diagnosis
to potentially prevent psychological suffering, dropout and involuntary
childlessness.
Prognosis and chances of success
Putting genetic inheritance aside, we would be advising third-party
reproduction right from the beginning in cases of poor prognosis and
would be performing these techniques much sooner. Although most
societies and authorities recommend oocyte donation when previous
IVF cycles fail, there is no mention as to what a reasonable number of
failed cycles should be.
Live birth rate (LBR) per embryo transfer with egg or embryo
donation is above 50%, and the odds of a live birth (LB) are signiﬁcantly
higher in donor IVF cycles than autologous cycles (odds ratio: 1.26,
95% conﬁdence interval: 1.18–1.33, adjusting for patient age, number
of oocytes retrieved, and number of embryos transferred) (Yeh et al.,
2014). The odds of not having a LB decrease not only with the use of
own oocytes and female age but also with treatment history and each
ART cycle (Templeton et al., 1996; Nelson and Lawlor, 2011; Vaegter
et al., 2017). This means that we might be contributing to unnecessary
burden in some couples, repeating cycles with their own gametes that
should be, sooner rather than later, transitioned to donation. This
subject is even more important if we consider that reproductive health
professionals have difficulties in guiding patients with poor prognosis
to use donated gametes in the face of the high hopes and unrealistic
expectations they show (Klitzman, 2016).
After an unsuccessful cycle, couples often face difficult decisions
around continuation or cessation of treatment (Mesquita da Silva et al.,
2018) and, even in a situation independent of ﬁnancial constraints,
many couples are noted as discontinuing treatment due to the psycho-
logical burden and lost hope of success (Lande et al., 2015). With all
but themost severe (zero-chance) prognoses, once started on an own-
genes route couples will often feel the need to pursue this, potentially
enticed by hope associated with patient-friendly offers of advanced
scientiﬁc technologies and interventions.
A key question to answer may be ‘are patients on the wrong path
when the real problem is being childless?’ There have been many
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detailed discussions of childlessness (e.g. Kreyenfeld, 2018). Of note,
the study of Vikstrom et al. (2015) found few mental health problems
in women who had undergone IVF 20 years before compared to a
reference group, but found increased levels of depression and phobic
anxiety in all women who remained childless compared to those who
had since becomemothers. Having an unfulﬁlled child-wish after fertility
treatment is associated with worse mental health for women even if
they already had children (Gameiro et al., 2014). For a 40-year-old
European woman with average height and weight (primary infertility,
not diagnosed), the probability of this wish to be fulﬁlled with her own
eggs is 23%, against 55% if she opts for oocyte donation (Luke et al.,
2014). ART providers should also keep in mind that around one in
four patients discontinue treatment (Brandes et al., 2011; Pedro et al.,
2017); it is then perhaps tempting to consider for these couples that a
much earlier discussion of alternatives may have helped their treatment
journey.
Understanding genomes and
heritability
As genomic ancestry technologies have gained widespread availability,
individuals have tended to become more aware of the concept of their
personal genome. However, there may be a lack of awareness that in
terms of coding genes, those we think of as ‘creating’ a child, over half
are in common with even plants and most are in common with animal
species. When we look at human genome variation, current data sug-
gests that individuals may have >4 million differences compared with
the reference genome, with ∼2000 of these associated with complex
traits, >25 of which may have negative disease implications (Sudmant
et al., 2015). This sounds like an incredible amount of unique differ-
ence, but the relevance for the randommix of 50%of these differences,
both positive and negative, (with those from the other gamete) means
that to consider the coding genes alone as the key piece of parental
inheritance may be considered somewhat misguided. Patients may also
have concepts that attribute more properties to these genetic variants,
in terms of the day-to-day physiology and psychology of their child,
than evidence supports. This is separate to those couples with genetic-
based fertility issues, such as Y-deletions or recessive genetic disorders,
who still wish to pass these along rather than consider ‘non-own genes’
children.
The astounding recent advances in genomics are also inﬂuencing
the public opinion to be more pro ‘nature’ in the debate of nature
versus nurture (Plomin, 2013). Recipient candidates for third-party
reproduction often inquire about the inﬂuence of genetics and ask
if donors were screened for cognitive and personality traits such as
intelligence or neuroticism. Though heritability estimates are in general
between 30 and 50% regarding personality (Plomin and Deary, 2015),
it has now been well established that experiences and the environment
inﬂuence the expression of personality (Briley and Tucker-Drob, 2014;
Baumert et al., 2017). There is now also solid evidence that while
heritability of personality traits decreases over the lifespan, environ-
mental inﬂuence increases (Wrzus and Roberts, 2017). In the end, the
way that each individual perceives their experiences and rates them
in terms of its relevance and inﬂuence is what makes siblings very
different. In a process with an increasing sense of loss of control,
patients seem to forget that one of the goals of parenting is the
D
ow
nloaded from
 https://academ
ic.oup.com
/hum
rep/advance-article-abstract/doi/10.1093/hum
rep/dez256/5698586 by U
niversidade do Porto user on 13 January 2020
Genes versus children—optimal approach for parenthood 3
socialisation of personality. Sharing this kind of information might be
important to address some patient concerns such as the presump-
tion that there is a special bond between gamete donor and child
(Goedeke et al., 2015).
Whereas almost all of our coding genes may be the same, whomso-
ever they came from, the evolving ﬁeld of epigenetics is revealing that
non-genetic code effects can radically affect child health. This is perhaps
most interesting in new understandings of epigenetics where we now
know that the gestational mother’s lifestyle behaviour and nutritional
metabolic health have direct effects on the offspring; arguably larger
than those of any generalised developmental genetic predisposition
chance, as described above. This knowledge of the importance of
gestation is often neglected in early discussions with women but may
be key in decision-making and acceptance when prospectively choosing
own over donor-oocyte treatment.
Risk to a child
Our discussion so far has focused upon the potential consequences and
thoughts related to childlessness on an individual. However, we should
also not fail to consider the potential consequences to succeeding
generations of offspring in pursuing an own-genes approach. Indeed,
with 5% of Northern European children conceived by ART, approaches
that may increase the likelihood of unhealthy individuals also become
a public health issue. Couples sometimes perceive potential outcomes
of a lack of genetic link as giving rise to physically or psychologically
unhealthy child (Eisenberg et al., 2010), but conversely, there are no
reports of concerns with using own-genes ‘old eggs’ or ‘damaged
sperm’. Age of both mothers and fathers at time of conception is
associated with an increasing number of genetic mutations carried by
children and with increasing oxidative stress, which in turn is associated
with neurological diseases and childhood cancers (Xavier et al., 2019).
From ICSI to artiﬁcial oocyte activation by ionophore or MRT, the fast
and some what unchecked-pace of progress in assisted conception
has seen techniques emerge with even simple safety-to-offspring data
following on twenty or more years behind. ICSI using the father’s
sperm is associated with a higher risk of birth defects than ICSI with
donor sperm, and ICSI-conceived males appear to inherit the deﬁ-
cient spermatogenesis of their fathers (Berntsen et al., 2019). Indeed,
studies of children born by ART generally show higher perinatal and
child health risks than for those who are spontaneously conceived
(Berntsen, et al., 2019). In the case of MRT or in vitro gametogenesis
from stem cells, it seems certain that potential risks to offspring and
succeeding generations are higher than natural or donor conception,
but this remains barely discussed in the face of an own-genes demand
and highly publicised scientiﬁc endeavours. Equally there should be
caution that a eugenic approach of always using an ‘ideal’ donor is
not started; for good prognosis couples, ART works well and produces
many healthy children, these rates would indeed likely be even higher if
those of poorer prognosis were not included.When treatment success
rates for individuals would undoubtedly be higher and of clearer safety
with donor gametes or indeed where adoption could be considered
100% successful in having a child to raise, when and where should
clinicians encourage couples to consider the safety of their offspring in
treatment choices? This needs urgent consideration as the use of these
treatments is here now. It is notable that regulators often decide to
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allow novel treatments even when scant safety data is available (e.g. in
UK, the Human Fertilisation and Embryology Authority allows oocyte
activation and MRT): this can not only be judged as supporting patient
choice but may also be providing further fuel to the concept of own-
genes being of prime importance in parenting.
Long-term psychosocial
consequences of donor gamete use
Disclosure to the future child about their mode of conception has been
probably the most studied and controversial subject when it comes
to decision-making to pursue this course of treatment. Although it
has been widely advised due to the potential psychological harms of
secrecy and underestimation of medical issues, less than half of parents
with children aged 10 years and older report having disclosed to them
(Zanchettin et al., 2016). Parents who opted for anonymity have shared
apprehensions about health and accidental contact between donor-
siblings (Nelson et al., 2015). With the guarantee of anonymity no
longer being a possibility in the near future due to direct-to-consumer
DNA testing (Harper et al., 2016) and increasing legal frameworks of
openness (including retrospective legislation), we expect the scenario
to change.
Prospective parents have concerns about how they will be perceived
as parents without a genetic tie, and these concerns can remain
in the absence of resemblance to the child (Isaksson et al., 2019).
However, the anxiety underlying the lack of biological ties decreases
after birth, and conﬁdence about the importance of socialisation
increases (Indekeu et al.,2014). In qualitative studies, donor recipients
use descriptions like ‘doing parenthood’ (Nordqvist & Smart, 2014) or
‘resemblance through nurture’ (Isaksson et al., 2019).
We now have some evidence that both donor-conceived children
(from early childhood to adolescence) and their parents are psychologi-
cally well adjusted and do not differ from families with spontaneously or
own-gamete conceived children (e.g. Golombok et al., 2011; Golom-
bok et al., 2013; Golombok et al., 2017). High relationship quality
has also been shown between mother and infant, with similar repre-
sentations between both genetically related fathers and non-related
(Golombok et al., 2005; Imrie et al., 2018).
Early disclosure therefore does not seem to pose difficulties in
terms of psychological adjustment. In a qualitative study involving
44 adolescents whose parents used third-party ART and disclosed
the mode of conception, Zadeh et al. (2018) found that the vast
majority (36) felt indifferent about their conception. A prospective
study suggests that amongst adolescents who were told about their
biological origins, those who knew before the age of 7 years had higher
psychological adjustment and family relationship quality (Ilioi et al.,
2017). There has been considerable questioning and debate around
the beneﬁts of disclosure versus non-disclosure (e.g. Crawshaw et al.,
2017; Golombok, 2017; Pennings, 2017a, 2017b), with research being
still scarce and insufficient. The available evidence suggests that there
is no deleterious effect of secrecy when comparing adolescents who
were not told with those who were told (Kovacs et al., 2015; Ilioi
et al. 2017). There are, however, narratives of shock and disbelief in
adults who found out that they were donor-conceived at adolescence
or adulthood (Frith et al., 2018). These can become more intricate
if donation occurred within an anonymous legislation system and
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when the discovery is made through direct-to-consumer DNA testing,
including the ﬁnding of siblings (Crawshaw, 2018). It is also curious to
notice that in couples who were followed up for 10 years, the divorce
rate of couples who had used gamete donation was not signiﬁcantly
different from those who had conceived naturally (Blake et al., 2012).
This is especially interesting if we consider that in a study of over 40 000
ART patients compared with an age-matched control group from the
general population, the risk of divorce was attributed to childlessness,
regardless of having gone through ART (Martins et al., 2018). Again,
it might be worth taking a step back and putting the emphasis on
becoming a family over genetic relatedness.
The path of gamete donation is certainly not an option for everyone,
and there are patients who discard this possibility from the start. For
those who might be open to it, we therefore contest that information
regarding the success rates and exploration of the misconceptions
and myths involved should be included from the earliest stages of the
diagnostic and treatment pathway in order to guide couples.
Good decisions with good
information
At present, exploring the preconceptions and informing on the legal,
psychological and social implications of having a family when using
donated genetic material is the keystone of fertility counselling and is
recommended by the leading societies and regulators. However, opting
for gamete donation has been described as a process that starts after
many years of trying to conceive and unsuccessful treatment, with
recommendations of referral to a fertility counsellor in order to come
to terms with the decision (Greenfeld, 2015). Moreover, for many
counsellors, this still seems to be viewed as part of a process where
the focus on alternative ways of starting a family must be preceded by
grieving the loss of genetic parenthood and focus on the impact and
acceptance of infertility. We believe that the emphasis on this being a
grieving process may again over-emphasise to the individual a medico-
societal level of importance placed on their genetics.
A recent systematic review that included over 27 000 patients under-
going treatments, screenings or tests of any sort concluded that the
majority of participants overestimated the intervention beneﬁts and
underestimated harm (Hoffmann and Del Mar, 2015). It is well known
that ART patients especially tend to overestimate and have excessive
conﬁdence in the success of fertility treatment (Kamphuis et al., 2014).
In addition, patients might be using time-to-pregnancy as the preferred
outcome instead of LB, which can be related to evidence showing
that immediate health beneﬁts are perceived as more important to
patients than long-term ones (Albertini et al., 2017). Moreover, it is
rather upsetting to know that patients insist on using their own eggs and
sperm even when advised against it, and it is not unheard of for couples
to falsify their age to pursue ‘own-genetics’ (Klitzman, 2016). Making
sure that patients fully understand the chances of success is also clearly
important. Transparency of information is key: explaining to>40 years
old woman that less than one out of 10 women gets a baby when
using their own oocytes but three out of them succeed when using
donated oocytes may be received more clearly than stating that egg
donation increases the cumulative LBR for women aged over 40 years
from under 10% to 30% per embryo transfer (Human Fertilisation and
Embryology Authority, 2018).
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Discussing with patients what would be a successful outcome for
them could prove useful. This approach should include the potential
harms and beneﬁts of opting for both a child with missing genetic link(s)
and for a child with full progeny, including a prognosis-based chance
for success with cumulative success rates and time until live-born child.
When the optimal outcome is to take a baby home, de-stigmatised use
of donation for many would sit higher in the discussion than it currently
seems to.
In patients with poor prognosis, asking them what the meaning of
parenthood can be a good conversation starter. For many patients, the
only contact they seem to have with hereditability is at the time of
explaining that donors are matched in some traits, and hence genetics
is emphasised without even discussing it. Explaining the meaning of
genetics and heritability might lead to a more effective decision-making
process. However, while it is important to share with patients that we
are increasing our knowledge of the role of genetics at a very fast pace
and that a cumulative number of diseases and traits are being identiﬁed
through DNA testing, a counterbalance is necessary. Hereditability can
explain the variation amongst traits but not causality. For example, we
can explain to patients that height is a trait that has 90% of hereditability.
If we take data from a poor village in an underdeveloped country
100 years ago, men were on average much shorter than the country’s
present average, and still the hereditability was of 90%; sanitation and
nutrition then raised the height of the next generations.
In addition, patients should be given the option to explore their
preconceptions and share their fears about using gamete donation
earlier in their treatment. The lack of high clarity information provision
to patients from their GPs./fertility specialists about having a child
versus an own-genes child may reﬂect the difficulty in broaching the
subject of donor gametes as an option and anxiety about how to
balance the conversation.We also need to acknowledge that physicians
are not good at doing nothing (Watson, 1976) so may move towards
the standard offer of ART.
We are all aware of the current shortage of donors in many
countries. This should not mean that, because of a shortage, patients
with poor prognosis can be under treatment with their own gametes
while on a waiting list. Education on these issues might not only help
ART patients in making better informed decisions but also raise the
number of donors by including them in awareness campaigns.
Finally, we should note that we have not discussed religion within this
context. The balance of religious groups and adherence is itself evolving
(Hackett and McClendon, 2017), as this also leads to some countries
considering donation illegal. The views of the couple/individual should
always be taken and not assumed. Due consideration also needs to
be given to religion in a local and global context alongside ancestry
testing for the individuals and families concerned: in particular, where a
donor may be regarded as the father of the child, after genetic testing,
in a different judicial system outside that where treatment occurs, but
where the donor or their family may at some stage be subject to the
law of that other country.
Conclusion
We believe that the wording used publicly and with patients must
reﬂect and balance that a wish to become parents need not focus upon
increasingly technical and potentially risky and unsuccessful measures
to propagate one’s genes. In fact, an optimal medical approach should
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consider as the major decider the wish of the couple for parenthood
and explain in a balanced manner the likelihood of this in the differing
scenarios they face. However, the importance of carefully providing
these choices at the start of the entire process is a key. As a cou-
ple begins a journey towards assisted conception, particularly when
ﬁnancial resources are limited, they need from the start to be able
to consider whether they are aiming to replicate their genes and/or
have children, where is the balance and what is most important to
them. Only when we provide patients with the service of a clear and
transparent discussion of these matters, we will really realise the true
potential of our ﬁeld, which may then be better considered as assisted
families.
Key messages for current practice are as follows:
(i) A ﬁnding of reproductive difficulty is a surprise tomost individuals.
Information provided in these early stages of anxiety through
medical contact helps form their future expectations. Early pro-
vision of balanced information with realistic discussions of rates
of childlessness may help to better guide decisions.
(ii) Fertility clinics should make sure that patients have a clear idea of
their success rates with different options, at regular intervals of
time.
(iii) With the increasing options and advances aimed to assist genetic
continuity in ART, there is a danger that individuals delay the
process of becoming parents, potentially even contributing to
childlessness.
(iv) Counselling is of paramount importance to every couple with a
poor prognosis, not only for those who have already had repeated
failures with their own gametes and are considering donation.
Patients should be given the opportunity to expose their expec-
tations and preconceptions about the impact of hereditability and
environmental inﬂuences.
(v) Patients should be informed about the impossibility of guarantee-
ing anonymity.
Next steps for research are as follows:
(i) Analysis of ART outcomes would beneﬁt from the results of LBR
per patient and number of previous cycles with type of treatment,
so that both reproductive healthcare professionals and patients
could better support their decisions to move to donation.
(ii) Comparison studies of long-term health outcomes in donor-
conceived children versus autologous cycles are needed to demys-
tify the concerns of patients who have opted for donation regard-
ing the health of the future children.
(iii) Randomised controlled trials are needed to test if getting a
personalised assessment of success rates with decision-making
approaches increases the patient’s understanding of prognostic
information.
(iv) Research is needed to know if education on inheritability and
attachment and exploration of fears regarding the use of gamete
donation might lead to faster decisions (including the option for
a childfree lifestyle), lower dropout rates and less involuntary
childless individuals with a sustained child-wish.
(v) Further studies on the psychosocial outcomes in donor-conceived
children, and their families and donors, versus autologous cycles
are needed to further allay concerns of patients and some health-
care practitioners.
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